Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 178 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review.
Khene ZE, Tachibana I, Bertail T, Fleury R, Bhanvadia R, Kapur P, Rajaram S, Guo J, Christie A, Pedrosa I, Lotan Y, Margulis V
World J Urol, 42(1):541, 26 Sep 2024
Cited by: 0 articles | PMID: 39325194
Add to export list Review
Prognostic models for predicting oncological outcomes after surgical resection of a nonmetastatic renal cancer: A critical review of current literature.
Khene ZE, Bhanvadia R, Tachibana I, Bensalah K, Lotan Y, Margulis V
Urol Oncol, S1078-1439(24)00631-8, 19 Sep 2024
Cited by: 0 articles | PMID: 39304391
Add to export list Review
Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN).
Gunenc D, Issa W, Gerald T, Zhou Q, Zhang S, Ibezue IC, Bhanvadia R, Tachibana I, Brugarolas J, Hammers H, Qin Q, Kapur P, Woldu S, Gaston K, Lotan Y, Cadeddu J, Wang AZ, Margulis V, Zhang T
Clin Genitourin Cancer, 22(5):102177, 23 Jul 2024
Cited by: 0 articles | PMID: 39218752
Add to export list
Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial.
Bahler CD, Tachibana I, Tann M, Collins K, Swensson JK, Green MA, Mathias CJ, Tong Y, Yong C, Boris RS, Brocken E, Hutchins GD, Sims JB, Hill DV, Smith N, Ferari C, Love H, Koch MO
J Urol, 212(2):290-298, 24 May 2024
Cited by: 1 article | PMID: 38785259
Add to export list
Reconsidering nephron-sparing strategies for the management of small renal tumors: a call for the inclusion of level 1 evidence in the debate.
Khene ZE, Tachibana I, Bhanvadia R, Lotan Y, Margulis V
Transl Androl Urol, 13(6):1049-1052, 11 Jun 2024
Cited by: 0 articles | PMID: 38983469
Add to export list
Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy.
McFadden J, Tachibana I, Adra N, Collins K, Cary C, Koch M, Kaimakliotis H, Masterson TA, Rice KR
Urol Oncol, 42(3):69.e11-69.e16, 23 Jan 2024
Cited by: 1 article | PMID: 38267301
Add to export list
Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC.
Kinehara Y, Shiroyama T, Tamiya A, Tamiya M, Minami S, Kanazu M, Morimura O, Niki T, Tetsumoto S, Taniguchi Y, Kuge T, Nishino K, Nagatomo I, Kumanogoh A, Tachibana I
JTO Clin Res Rep, 4(11):100586, 12 Oct 2023
Cited by: 0 articles | PMID: 38029024 | PMCID: PMC10679942
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
Antonelli L, Ardizzone D, Tachibana I, Adra N, Cary C, Hugar L, Sexton WJ, Bagrodia A, Mego M, Daneshmand S, Nicolai N, Nazzani S, Giannatempo P, Franza A, Heidenreich A, Paffenholz P, Saoud R, Eggener S, Ho M, [...] EAU-YAU Penile and Testis Cancer Working Group
J Clin Oncol, 41(34):5296-5305, 01 Sep 2023
Cited by: 1 article | PMID: 37656935
Add to export list
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
Jacob JM, Woldu SL, Linehan J, Labbate C, Rose KM, Sexton WJ, Tachibana I, Kaimakliotis H, Nieder A, Bjurlin MA, Humphreys M, Ghodoussipour SB, Quek ML, Johnson B, O'Donnell M, Eisner BH, Feldman AS, Murray KS, Matin SF, [...] Dickstein RJ
Urol Oncol, 42(1):20.e17-20.e23, 28 Jul 2023
Cited by: 1 article | PMID: 37517898
Add to export list
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy.
Tachibana I, Alabd A, Whaley RD, McFadden J, Piroozi A, Hassoun R, Kern SQ, King J, Adra N, Rice KR, Foster RS, Einhorn LH, Cary C, Masterson TA
Urol Oncol, 41(9):394.e1-394.e6, 04 Aug 2023
Cited by: 0 articles | PMID: 37543446
Add to export list
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.
Kaimakliotis HZ, Tachibana I, Woldu S, Labbate C, Jacob J, Murray K, Rose K, Sexton W, Dickstein R, Linehan J, Nieder A, Bjurlin M, Humphreys M, Ghodoussipour S, Quek M, O'Donnell M, Eisner BH, Matin SF, Lotan Y, Feldman AS
Urol Oncol, 41(9):387.e1-387.e7, 26 May 2023
Cited by: 1 article | PMID: 37246135
Add to export list
Candida Pneumonia in a Young Vegan Man with Diabetic Ketoacidosis.
Yanagisawa A, Kinehara Y, Tanaka M, Ninomiya R, Nishioka M, Ochiai S, Jokoji R, Ihara S, Hashimoto K, Tachibana I
Intern Med, 62(24):3679-3683, 10 May 2023
Cited by: 0 articles | PMID: 37164677 | PMCID: PMC10781560
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Tachibana I, Alabd A, Tong Y, Piroozi A, Mahmoud M, Kern SQ, Masterson TA, Adra N, Foster RS, Hanna NH, Einhorn LH, Cary C
J Clin Oncol, 41(23):3930-3938, 02 Feb 2023
Cited by: 4 articles | PMID: 36730902
Add to export list
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.
Labbate C, Woldu S, Murray K, Rose K, Sexton W, Tachibana I, Kaimakliotis H, Jacob J, Dickstein R, Linehan J, Nieder A, Bjurlin M, Humphreys M, Ghodoussipour S, Quek M, O'Donnell M, Eisner B, Feldman A, Lotan Y, Matin SF
J Urol, 209(5):872-881, 19 Jan 2023
Cited by: 5 articles | PMID: 36657029
Add to export list
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.
Woldu SL, Labbate C, Murray KS, Rose K, Sexton W, Tachibana I, Kaimakliotis H, Jacob J, Dickstein R, Linehan J, Nieder A, Bjurlin MA, Humphreys M, Ghodoussipour S, Quek ML, O'Donnell M, Eisner BH, Feldman AS, Matin SF, Lotan Y
Urol Oncol, 41(3):147.e15-147.e21, 22 Nov 2022
Cited by: 1 article | PMID: 36424224
Add to export list
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Tachibana I, Kern SQ, Douglawi A, Tong Y, Mahmoud M, Masterson TA, Adra N, Foster RS, Einhorn LH, Cary C
Eur Urol, 83(1):e20-e21, 01 Oct 2022
Cited by: 0 articles | PMID: 36195478
Add to export list
Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
Tachibana I, Vasquez R, Mahmoud M, Kern SQ, Patel RS, King J, Adra N, Boris RS, Cary C, Rice KR
Urol Oncol, 40(11):495.e11-495.e17, 22 Sep 2022
Cited by: 2 articles | PMID: 36154800
Add to export list
Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib.
Yanagisawa A, Kinehara Y, Kijima R, Tanaka M, Ninomiya R, Jokoji R, Tachibana I
Intern Med, 62(5):769-773, 22 Jul 2022
Cited by: 3 articles | PMID: 35871578 | PMCID: PMC10037001
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
Tachibana I, Kern SQ, Douglawi A, Tong Y, Mahmoud M, Masterson TA, Adra N, Foster RS, Einhorn LH, Cary C
J Clin Oncol, 40(32):3762-3769, 08 Jun 2022
Cited by: 3 articles | PMID: 35675585
Add to export list
In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease.
Kadota K, Matsumoto K, Uchiyama H, Tobita S, Maeda M, Maki D, Kinehara Y, Tachibana I, Sosnowski TR, Tozuka Y
Eur J Pharm Biopharm, 174:10-19, 26 Mar 2022
Cited by: 5 articles | PMID: 35351571
Add to export list
Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.
Ninomiya R, Kinehara Y, Tobita S, Konaka H, Jokoji R, Shintani T, Tachibana I
Intern Med, 61(15):2339-2341, 13 Jan 2022
Cited by: 4 articles | PMID: 35022350 | PMCID: PMC9424081
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?
Tachibana I, Mahmoud M, Abedali ZA, Flack C, Adra N, Cheng L, Kaimaklitois HZ
Urol Oncol, 40(5):196.e11-196.e16, 08 Feb 2022
Cited by: 0 articles | PMID: 35148949
Add to export list
FIP1L1-PDGFRA fusion gene in a patient with asthma and rhinitis.
Sato M, Kato R, Jokoji R, Tachibana I
BMJ Case Rep, 14(5):e242096, 27 May 2021
Cited by: 0 articles | PMID: 34045202 | PMCID: PMC8162092
Add to export list Free full text in Europe PMC
Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach.
Tachibana I, Calaway AC, Abedali Z, Szymanski KM, Mellon MJ, Masterson TA, Cary C, Kaimakliotis HZ, Boris RS
Urol Oncol, 39(11):789.e1-789.e7, 08 Jul 2021
Cited by: 0 articles | PMID: 34247908
Add to export list
Boosting Auto-Induction of Recombinant Proteins in Escherichia coli with Glucose and Lactose Additives.
Tahara N, Tachibana I, Takeo K, Yamashita S, Shimada A, Hashimoto M, Ohno S, Yokogawa T, Nakagawa T, Suzuki F, Ebihara A
Protein Pept Lett, 28(10):1180-1190, 01 Jan 2021
Cited by: 5 articles | PMID: 34353248 | PMCID: PMC8811614
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 178 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review.

Prognostic models for predicting oncological outcomes after surgical resection of a nonmetastatic renal cancer: A critical review of current literature.

Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN).

Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial.

Reconsidering nephron-sparing strategies for the management of small renal tumors: a call for the inclusion of level 1 evidence in the debate.

Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy.

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC.

Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.

Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy.

The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.

Candida Pneumonia in a Young Vegan Man with Diabetic Ketoacidosis.

Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?

Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.

Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.

Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.

Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib.

Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?

In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease.

Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.

Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?

FIP1L1-PDGFRA fusion gene in a patient with asthma and rhinitis.

Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach.

Boosting Auto-Induction of Recombinant Proteins in Escherichia coli with Glucose and Lactose Additives.

Partnerships & funding